Log In
Print this Print this

OncoBEAM RAS CRC assay

  Manage Alerts
Collapse Summary General Information
Company Sysmex Corp.
DescriptionBlood-based Ras biomarker test
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsDetect Ras mutations in patients with metastatic colorectal cancer and determine which patients would benefit from anti-EGFR treatment
Regulatory Designation
PartnerMerck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today